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Abstract
Macromomycin (MCR), an unique membrane-reactive anticancer antibiotic, was incubated
with murine monoclonal anti-HLA IgG1 antibody (H-1) in the presence of carbodiimide. The
resulting mixture was fractionated with a Sephadex G-200 column. The first and second fractions
were shown to contain MCR-(H-1) conjugate by the elution profile, as well as by the Sarcina lutea
growth inhibition assay and Ouchterlony double-diffusion method. A membrane immunofluores-
cence test with anti-MCR and anti-mouse IgG antibodies demonstrated specific localization of
MCR-(H-1) on the surface of HLA-bearing NALL -1 cells. MCR-(H-1) inhibited the growth of
HLA-lacking NS-1 cells statistically less effectively than MCR alone (p less than 0.01). On the
other hand, the conjugate and free MCR equally inhibited the growth and 3H-TdR incorporation
of HLA-bearing NALL -1 cells. These results indicate that the antibody-bound MCR retained both
MCR and antibody activities, and thus exerted antibody-targeting MCR cytotoxicity in vitro.
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